Edition:
India

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

69.18USD
20 Jul 2018
Change (% chg)

$-1.67 (-2.36%)
Prev Close
$70.85
Open
$71.35
Day's High
$71.62
Day's Low
$68.58
Volume
27,676
Avg. Vol
32,834
52-wk High
$76.29
52-wk Low
$26.60

Chart for

About

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone... (more)

Overall

Beta: --
Market Cap(Mil.): $1,304.09
Shares Outstanding(Mil.): 36.37
Dividend: --
Yield (%): --

Financials

BRIEF-Ascendis Pharma Announces Dosing Of First Subjects In Phase 1 Trial Of Transcon CNP

* ASCENDIS PHARMA A/S ANNOUNCES DOSING OF FIRST SUBJECTS IN PHASE 1 TRIAL OF TRANSCON CNP

08 May 2018

BRIEF-Ascendis Pharma Reports Full Year 2017 Financial Results

* ASCENDIS PHARMA A/S REPORTS FULL YEAR 2017 FINANCIAL RESULTS

29 Mar 2018

BRIEF-Ascendis Pharma prices 3.9 mln American Depositary Shares At $57 Per ADS

* ASCENDIS PHARMA A/S ANNOUNCES PRICING OF PUBLIC OFFERING OF ADSS

22 Feb 2018

BRIEF-Ascendis Pharma A/S Announces Proposed Public Offering Of ADSS

* ASCENDIS PHARMA A/S ANNOUNCES PROPOSED PUBLIC OFFERING OF ADSS

21 Feb 2018

Competitors

Earnings vs. Estimates